Purchases and Sales Made in Q4 2024 in Atea Pharmaceuticals, Inc. (AVIR)
This table provides information about the institutional ownership of Atea Pharmaceuticals, Inc. (AVIR) during Q4 2024. The information is specifically focused on institutions that hold shares of Atea Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 06, 2025
Q4 2024
|
Bml Capital Management, LLC
Zionsville, IN |
BUY
|
- |
958K+ 14.41% |
$2.81M - $3.66M
|
7.61M
$22.7M
|
|
Jan 29, 2025
Q4 2024
|
Peapod Lane Capital LLC
Bedford Hills, NY |
BUY
|
- |
329KNew |
$963K - $1.26M
|
329K
$979K
|
|
Feb 07, 2025
Q4 2024
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
- |
50.1KNew |
$147K - $191K
|
50.1K
$149K
|
|
Feb 07, 2025
Q4 2024
|
Cm Management, LLC
|
BUY
|
- |
30K+ 11.11% |
$87.9K - $115K
|
300K
$894K
|
|
Feb 06, 2025
Q4 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
9.37K+ 1.44% |
$27.5K - $35.8K
|
660K
$1.97M
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
1.67K+ 10.3% |
$4.9K - $6.39K
|
17.9K
$53.4K
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
1.49K+ 4.85% |
$4.35K - $5.68K
|
32.1K
$95.7K
|
|
Feb 04, 2025
Q4 2024
|
Cwm, LLC
|
BUY
|
- |
123+ 455.56% |
$360 - $470
|
150
$447
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
2New |
$5.86 - $7.64
|
2
$5.96
|
|
Feb 04, 2025
Q4 2024
|
Ifp Advisors, Inc
|
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 07, 2025
Q4 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-58- 1.2% |
$170 - $222
|
4.78K
$14.2K
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-105- 82.03% |
$308 - $401
|
23
$68.5
|
|
Jan 27, 2025
Q4 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-238- 7.8% |
$697 - $909
|
2.82K
$8.39K
|
|
Feb 07, 2025
Q4 2024
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
SELL
|
- |
-1.47K- 96.77% |
$4.3K - $5.6K
|
49
$146
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-3.32K- 2.49% |
$9.72K - $12.7K
|
130K
$387K
|